Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells.

Authors
Type
Published Article
Journal
Cardiovascular therapeutics
Publication Date
Volume
31
Issue
2
Pages
115–123
Identifiers
DOI: 10.1111/j.1755-5922.2011.00305.x
PMID: 22212466
Source
Medline
License
Unknown

Abstract

Bivalirudin is better than UFH in reducing periprocedural platelet activation. Moreover, thrombin-induced TF expression is inhibited by bivalirudin. Thus, bivalirudin seems to be a better anticoagulant during PCI than UFH.

Statistics

Seen <100 times